Edwards Lifesciences Corp Capital Reinvestment Ratio
Edwards Lifesciences Corp capital reinvestment ratio. Edwards Lifesciences Corp (EW) has a Capital Reinvestment Ratio of 0.10x as of June 2026, meaning it reinvests 0% of its operating cash flow ($651.90 Million) in capital expenditures ($66.90 Million). Check EW cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Edwards Lifesciences Corp (1999–2025)
Capital reinvestment ratio of Edwards Lifesciences Corp from 1999 to 2025. This chart tracks Edwards Lifesciences Corp's Capital Reinvestment Ratio across 27 annual periods. Also explore net asset momentum of Edwards Lifesciences Corp to track the company's year-over-year net asset growth rate.
Edwards Lifesciences Corp Capital Reinvestment Ratio by Year (1999–2025)
Edwards Lifesciences Corp capital reinvestment ratio by year from 1999 to 2025. For the full cash flow conversion analysis, see Edwards Lifesciences Corp (EW) cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.16x | $1.60 Billion | $260.20 Million | ▼ -65.0% |
| 2024 | 0.47x | $542.30 Million | $252.40 Million | ▲ +56.6% |
| 2023 | 0.30x | $895.80 Million | $266.30 Million | ▲ +36.8% |
| 2022 | 0.22x | $1.22 Billion | $264.80 Million | ▲ +14.2% |
| 2021 | 0.19x | $1.73 Billion | $329.80 Million | ▼ -50.7% |
| 2020 | 0.39x | $1.05 Billion | $407.30 Million | ▲ +63.7% |
| 2019 | 0.24x | $1.18 Billion | $278.40 Million | ▼ -9.5% |
| 2018 | 0.26x | $926.80 Million | $241.70 Million | ▲ +48.7% |
| 2017 | 0.18x | $1.00 Billion | $175.50 Million | ▼ -43.2% |
| 2016 | 0.31x | $704.40 Million | $217.40 Million | ▲ +59.3% |
| 2015 | 0.19x | $549.70 Million | $106.50 Million | ▲ +111.4% |
| 2014 | 0.09x | $1.02 Billion | $93.70 Million | ▼ -60.6% |
| 2013 | 0.23x | $472.70 Million | $110.10 Million | ▼ -31.8% |
| 2012 | 0.34x | $373.80 Million | $127.70 Million | ▲ +18.6% |
| 2011 | 0.29x | $314.50 Million | $90.60 Million | ▲ +15.0% |
| 2010 | 0.25x | $251.40 Million | $63.00 Million | ▼ -35.3% |
| 2009 | 0.39x | $165.30 Million | $64.00 Million | ▼ -24.0% |
| 2008 | 0.51x | $153.20 Million | $78.00 Million | ▲ +71.2% |
| 2007 | 0.30x | $210.20 Million | $62.50 Million | ▲ +15.5% |
| 2006 | 0.26x | $230.80 Million | $59.40 Million | ▼ -27.4% |
| 2005 | 0.35x | $136.80 Million | $48.50 Million | ▲ +50.7% |
| 2004 | 0.24x | $180.60 Million | $42.50 Million | ▼ -24.1% |
| 2003 | 0.31x | $122.30 Million | $37.90 Million | ▼ -8.2% |
| 2002 | 0.34x | $120.60 Million | $40.70 Million | ▼ -10.3% |
| 2001 | 0.38x | $101.00 Million | $38.00 Million | ▲ +12.1% |
| 2000 | 0.34x | $137.00 Million | $46.00 Million | ▲ +40.7% |
| 1999 | 0.24x | $176.00 Million | $42.00 Million | — |